Skip to content

New European call to boost innovation in paediatric epilepsy care through the i4KIDS-4RARE initiative

The i4KIDS-4RARE Neuropilepsy Innovation Programme, launched with EpiCARE, supports innovative solutions to improve early diagnosis, cognitive monitoring and personalised therapies for children with rare epilepsies. The call focuses on three key challenges to advance paediatric epilepsy care across Europe.
i4KIDS-4RARE Acceleration Programme

Through the European project i4KIDS-4RARE, coordinated by the paediatric innovation hub i4KIDS, the i4KIDS-4RARE Neuropilepsy Innovation Programme is launched. This is an initiative aimed at identifying and supporting innovative solutions that enhance early diagnosis, cognitive monitoring, and personalised therapeutic strategies for children with rare epileptic conditions.

Developed in collaboration with EpiCARE, the European Reference Network for rare and complex epilepsies, the programme is part of i4KIDS’ commitment to accelerating innovation in child health, with a special focus on rare diseases and orphan medical devices.

Three priority challenges to transform paediatric epilepsy care

The call is structured around three major challenges that address unmet clinical and technological needs:

  • Challenge 1: AI-Driven Neuroimaging for Surgical Planning
    Seeking solutions that improve the detection and localisation of epileptogenic foci through advanced neuroimaging analysis, enabling earlier and more precise surgical planning.
  • Challenge 2: Early Detection and Management of Cognitive Impairment
    Promoting tools that allow systematic and standardised monitoring of cognitive functions from the earliest stages, supporting personalised and child-centred interventions.
  • Challenge 3: Personalised Dosage Adjustment for Anti-Seizure Medications
    Encouraging solutions that integrate clinical, pharmacological, and genetic data to optimise treatment efficacy and reduce side effects, improving the quality of life of patients and their families.

Open innovation for a more inclusive ecosystem

The i4KIDS-4RARE call is open to proposals from diverse fields (technological, clinical, educational, or social) and at a development stage of TRL 7 or higher.

The goal is to foster collaboration among researchers, clinicians, companies, start-ups, and patient associations, and to accelerate the arrival of new tools that can be integrated into clinical practice and scaled across Europe.

Submission of proposals

The call will remain open until 30 November 2025.
The selected proposal will receive support for its development, validation, and connection with the European paediatric innovation network promoted by i4KIDS.

More information and access to the application form:
👉 https://www.innovation4kids.org/en/i4kids4rare-neuropilepsy-innovation-programme/

About the author
i4KIDS
Content by i4KIDS
Related News
Montana Impact Fund

Featured

The CDTI and the European Investment Fund have announced a joint investment of €30 million in Montana Children’s Health, the first European fund specialising in innovation in children’s health. The initiative, driven from the outset with the active participation of i4KIDS, seeks to transform deep‑tech research into clinical and technological solutions that improve the lives of children across Europe.
jornad

Featured

The eleven R&D&I networks of Catalonia gathered for a day focused on strengthening collaboration and knowledge transfer. i4KIDS played an active role in the event, sharing its experience in paediatric innovation and contributing to the identification of new opportunities to generate social impact through research.
i4Kids PAediatric Innovation day

Featured

The 6th i4KIDS Paediatric Innovation Day brought together more than 400 participants in Barcelona on World Children’s Day, reaffirming its role as a leading international forum for innovation in fetal, paediatric and maternal health. The event featured keynotes, expert discussions, research highlights and a dynamic pitch competition showcasing solutions designed to improve children’s health and wellbeing.